Health Matters: FDA links weight-loss drug to cancer
<p>The Federal Drug Administration recalled prescription weight-loss drug Belviq because it's been linked to cancer.</p><p></p>
•
Feb 14, 2020, 4:43 PM
•
Updated 1,915 days ago
Share:
The Federal Drug Administration recalled prescription weight-loss drug Belviq because it's been linked to cancer.
The generic name for the drug is Lorcaserin.
The FDA started taking a close look at it last month.
Clinical trials showed people who take it could end up getting cancer.
Thursday the FDA asked the company to take it off the market.
More from News 12
0:34
Jury selection begins for former Norwalk official accused of killing her tenant
1:13
Grab the umbrellas! On-and-off rain expected Wednesday
2:05
Yale School of Medicine doctor back from helping surgeons in the war in Ukraine
1:00
Goldman Sachs says 35% chance of a recession in the next year
0:32
Buddy the Beefalo living free after pandemic-era escape from Connecticut slaughterhouse
0:36
